EndMT is known to be initiated by TGFB1, and is exacerbated by TNF in cancer-associated fibroblasts (Yoshimatsu et al., 2020); therefore, it is possible that the increases in content of TNF and TGFB1 during luteal regression can contribute to EndMT. The gene discussed is TGFB1; the disease is cancer.